BEAM
Price
$24.41
Change
-$1.90 (-7.22%)
Updated
Nov 15, 03:09 PM (EDT)
109 days until earnings call
JAZZ
Price
$121.87
Change
-$2.40 (-1.93%)
Updated
Nov 15, 03:28 PM (EDT)
109 days until earnings call
Ad is loading...

BEAM vs JAZZ

Header iconBEAM vs JAZZ Comparison
Open Charts BEAM vs JAZZBanner chart's image
Beam Therapeutics
Price$24.41
Change-$1.90 (-7.22%)
Volume$600
CapitalizationN/A
Jazz Pharmaceuticals
Price$121.87
Change-$2.40 (-1.93%)
Volume$100
CapitalizationN/A
BEAM vs JAZZ Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BEAM vs. JAZZ commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and JAZZ is a StrongBuy.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (BEAM: $26.31 vs. JAZZ: $124.27)
Brand notoriety: BEAM and JAZZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 92% vs. JAZZ: 145%
Market capitalization -- BEAM: $2.18B vs. JAZZ: $7.51B
BEAM [@Biotechnology] is valued at $2.18B. JAZZ’s [@Biotechnology] market capitalization is $7.51B. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileJAZZ’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • JAZZ’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while JAZZ’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • JAZZ’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, JAZZ is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +0.80% price change this week, while JAZZ (@Biotechnology) price change was +4.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.93%. For the same industry, the average monthly price growth was -3.18%, and the average quarterly price growth was +1.55%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

JAZZ is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-5.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($7.51B) has a higher market cap than BEAM($2.18B). JAZZ YTD gains are higher at: 1.033 vs. BEAM (-3.343).
BEAMJAZZBEAM / JAZZ
Capitalization2.18B7.51B29%
EBITDAN/AN/A-
Gain YTD-3.3431.033-324%
P/E RatioN/A17.60-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
JAZZ: Fundamental Ratings
JAZZ
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
64
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMJAZZ
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
61%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 4 days ago
63%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
67%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
JAZZ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-4.33%
CRSP - BEAM
75%
Closely correlated
-5.90%
NTLA - BEAM
68%
Closely correlated
-6.15%
DNLI - BEAM
65%
Loosely correlated
-3.98%
EDIT - BEAM
64%
Loosely correlated
-6.42%
RXRX - BEAM
61%
Loosely correlated
-5.60%
More

JAZZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAZZ has been loosely correlated with REGN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if JAZZ jumps, then REGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAZZ
1D Price
Change %
JAZZ100%
-2.65%
REGN - JAZZ
37%
Loosely correlated
-2.71%
INCY - JAZZ
37%
Loosely correlated
-3.42%
NTLA - JAZZ
36%
Loosely correlated
-6.15%
IKNA - JAZZ
36%
Loosely correlated
-1.72%
BEAM - JAZZ
34%
Loosely correlated
-4.33%
More